Publicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (12)

2022

  1. Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs

    Human Brain Mapping, Vol. 43, Núm. 1, pp. 300-328

2021

  1. 1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans

    Translational psychiatry, Vol. 11, Núm. 1, pp. 182

  2. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis

    Frontiers in Pharmacology, Vol. 12

2020

  1. Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region with Cortical and Subcortical Morphology and Cognition

    JAMA Psychiatry, Vol. 77, Núm. 4, pp. 420-430

  2. Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia

    Molecular Psychiatry, Vol. 25, Núm. 3, pp. 584-602

2019

  1. Altered gene expression in antipsychotic-induced weight gain

    npj Schizophrenia, Vol. 5, Núm. 1

  2. Sex differences in gene expression related to antipsychotic induced weight gain

    PLoS ONE, Vol. 14, Núm. 4

  3. Time dependent expression of the blood biomarkers EIF2D and TOX in patients with schizophrenia

    Brain, Behavior, and Immunity, Vol. 80, pp. 909-915

2018

  1. Blood gene expression profile predicts response to antipsychotics

    Frontiers in Molecular Neuroscience, Vol. 11

2016

  1. Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson's disease

    Neurobiology of Aging, Vol. 38, pp. 214.e1-214.e5

2015

  1. Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls

    Neurobiology of Aging, Vol. 36, Núm. 2, pp. 1105-1109

2014

  1. Schizophrenia gene expression profile reverted to normal levels by antipsychotics

    International Journal of Neuropsychopharmacology, Vol. 18, Núm. 4, pp. 1-7